Rockline Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3M Buy
56,191
+59
+0.1% +$17.9K 4.66% 3
2026
Q1
$12M Sell
56,132
-1,923
-3% -$430K 2.61% 8
2025
Q4
$9.94M Buy
58,055
+2,292
+4% +$356K 2.03% 13
2025
Q3
$7.47M Buy
55,763
+4,883
+10% +$517K 1.55% 16
2025
Q2
$4.95M Buy
50,880
+2,868
+6% +$227K 1.17% 24
2025
Q1
$3.49M Buy
48,012
+2,551
+6% +$201K 0.97% 33
2024
Q4
$3.28M Buy
45,461
+771
+2% +$58.5K 0.88% 36
2024
Q3
$3.65M Buy
44,690
+3,180
+8% +$276K 1.03% 31
2024
Q2
$4.42M Sell
41,510
-100
-0.2% -$9.59K 1.37% 18
2024
Q1
$4.04M Buy
41,610
+3,430
+9% +$302K 1.41% 24
2023
Q4
$2.99M Buy
+38,180
New +$2.6M 1.24% 28

Other funds holding LRCX

Rockline Wealth Management's LRCX Position: Q2 2026 in Review

Rockline Wealth Management increased its Lam Research (LRCX) stake by 0.11% in Q2 2026, buying an estimated $17.9K and bringing the position to 56,191 shares worth $24.3M. The position accounts for 4.66% of the portfolio, ranked #3.

Rockline Wealth Management first reported a position in LRCX in Q4 2023 and has held it in 11 quarters since. 3,108 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Rockline Wealth Management held 56,191 shares of Lam Research worth $24.3M as of Q2 2026.
  • Rockline Wealth Management bought 59 Lam Research shares in Q2 2026, an estimated $17.9K.
  • Lam Research made up 4.66% of Rockline Wealth Management's portfolio in Q2 2026, its #3 holding.
  • Rockline Wealth Management first reported a position in Lam Research in Q4 2023 and has held it in 11 quarters since.
  • 3,108 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Rockline Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.